Phenylacetate and Derivatives Alone or in Combination with Other Compounds Against Neoplastic Conditions and Other Disorders Read more about Phenylacetate and Derivatives Alone or in Combination with Other Compounds Against Neoplastic Conditions and Other Disorders Cyprus04030912.2Filed on 1994-10-12
Phenylacetate and Derivatives Alone or in Combination with Other Compounds Against Neoplastic Conditions and Other Disorders Read more about Phenylacetate and Derivatives Alone or in Combination with Other Compounds Against Neoplastic Conditions and Other Disorders Switzerland04030912.2Filed on 1994-10-12
Phenylacetate and Derivatives Alone or in Combination with Other Compounds Against Neoplastic Conditions and Other Disorders Read more about Phenylacetate and Derivatives Alone or in Combination with Other Compounds Against Neoplastic Conditions and Other Disorders Bulgaria04030912.2Filed on 1994-10-12
Phenylacetate and Derivatives Alone or in Combination with Other Compounds Against Neoplastic Conditions and Other Disorders Read more about Phenylacetate and Derivatives Alone or in Combination with Other Compounds Against Neoplastic Conditions and Other Disorders Belgium04030912.2Filed on 1994-10-12
Phenylacetate and Derivatives Alone or in Combination with Other Compounds Against Neoplastic Conditions and Other Disorders Read more about Phenylacetate and Derivatives Alone or in Combination with Other Compounds Against Neoplastic Conditions and Other Disorders Bosnia and Herzegovina04030912.2Filed on 2004-12-28
Phenylacetate and Derivatives Alone or in Combination with Other Compounds Against Neoplastic Conditions and Other Disorders Read more about Phenylacetate and Derivatives Alone or in Combination with Other Compounds Against Neoplastic Conditions and Other Disorders Austria04030912.2Filed on 1994-10-12
Phenylacetate and Derivatives Alone or in Combination with Other Compounds Against Neoplastic Conditions and Other Disorders Read more about Phenylacetate and Derivatives Alone or in Combination with Other Compounds Against Neoplastic Conditions and Other Disorders Albania04030912.2Filed on 1994-10-12
USE OF HISTONE DEACETYLASE INHIBITORS FOR THE TREATMENT OF CENTRAL NERVOUS SYSTEM METASTASES Read more about USE OF HISTONE DEACETYLASE INHIBITORS FOR THE TREATMENT OF CENTRAL NERVOUS SYSTEM METASTASES Patent Cooperation TreatyPCT/US2008/055149Filed on 2008-02-27
Triapine-induced Tumor Cell Radiosensitization Read more about Triapine-induced Tumor Cell Radiosensitization US Application 11/992,002Filed on 2009-08-13
METHODS OF TREATING OR PREVENTING CANCER USING PYRIDINE CARBOXALDEHYDE PYRIDINE THIOSEMICARBAZONE RADIOSENSITIZING AGENTS Read more about METHODS OF TREATING OR PREVENTING CANCER USING PYRIDINE CARBOXALDEHYDE PYRIDINE THIOSEMICARBAZONE RADIOSENSITIZING AGENTS European Patent06814743.8Filed on 2006-09-15